Niox Group Plc - Company Profile

Powered by

All the data and insights you need on Niox Group Plc in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Niox Group Plc Strategy Report

  • Understand Niox Group Plc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Niox Group Plc: Overview

Select Item

Niox Group Plc (Niox Group) formerly Circassia Group Plc (Circassia), is a medical device company that develops, design, commercialisation and manufactures drugs for the treatment of respiratory diseases such as asthma. The company's marketed products include Niox used for asthma management. The company major device NIOX VERO, a tool to improve the diagnosis and management of asthma. The company offers its products to asthma specialists in the Europe, Africa, North America, South America, Australasia, Asia and other countries through its network of partners. Niox Group is headquartered in Oxford, England, the UK.

 Gain a 360-degree view of Niox Group Plc and make more informed decisions for your business Gain a 360-degree view of Niox Group Plc and make more informed decisions for your business Find out more
Headquarters United Kingdom
Address Hayakawa Building, The Oxford Science Park, England, OX44GB
Website investors.niox.com
Telephone 44 1865 405560
No of Employees 85
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange NIOX (LON)
Revenue (2022) $45.8M 17.6% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -33.5% (2022 vs 2021)
Market Cap* $342.0M
Net Profit Margin (2022) XYZ -43.5% (2022 vs 2021)
* As of and is in US$
View Niox Group Plc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Niox Group Plc premium industry data and analytics

50+

Clinical Trials

Determine Niox Group Plc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

16+

Pipeline Drugs

Identify which of Niox Group Plc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

6

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

Sales & Consensus Forecasts

Understand the current and future drug revenue for Niox Group Plc and assess market opportunity for new entrants with patient population 8-year forecasts.

1

Marketed Drugs

Understand Niox Group Plc’s commercialized product portfolio to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Niox Group Plc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Marketed Niox Vero
Niox Niox
Feno Feno
Understand Niox Group Plc portfolio and identify potential areas for collaboration Understand Niox Group Plc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Niox Group Plc GSK plc ALK-Abello AS Clinigen Ltd Theravance Biopharma Inc
Headquarters United Kingdom United Kingdom Denmark United Kingdom United Kingdom
City Oxford Brentford Hoersholm Burton Upon Trent George Town
State/Province England England - England Cayman Islands
No. of Employees 85 70,212 2,824 1,150 99
Entity Type Public Public Public Private Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Ian Johnson Chairman Executive Board 2019 -
Michael Roller Director; Chief Financial Officer Executive Board 2020 -
Jonathan Emms Director; Chief Operating Officer Executive Board 2019 -
Jan Lundquist Vice President - Supply Chain and Technical Operations Senior Management 2015 -
Nina Kataria Senior Vice President - Global Human Resources Senior Management 2014 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Niox Group Plc key executives to enhance your sales strategy Gain insight into Niox Group Plc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward